Skip to main content
. 2012 Mar 1;7(3):e32711. doi: 10.1371/journal.pone.0032711

Table 3. Nass use and risk of ESCC in cases and controls in the two phases of the Golestan Case-Control Study of ESCC in Golestan Province, Iran.

Hospital study Neighborhood study P for heterogeneity adjusted ORs
ESCC% Control% CrudeOR (95% CI) Adjusted*OR (95% CI) ESCC% Control% CrudeOR (95% CI) Adjusted*OR (95% CI)
Nass
Never 110(85) 237(91) 1.00 1.00 256(85) 523(92) 1.00 1.00
Ever 20(15) 23(9) 1.89 (0.98–3.62) 1.82(0.89–3.70) 44(15) 48(8) 2.09 (1.28–3.42) 1.53(0.88–2.64) 0.71
Average amount (times per day)
Never 110(85) 237(91) 1.00 1.00 256(85) 523(92) 1.00 1.00
< = Median** 11(8) 12(5) 2.05 (0.85–4.93) 1.93(0.76–4.92) 17(6) 24(4) 1.59 (0.78–3.25) 1.11(0.52–2.39) 0.42
>Median 9(7) 11(4) 1.74 (0.71–4.22) 1.71(0.66–4.40) 27(9) 24(4) 2.52 (1.38–4.61) 1.90(0.98–3.66) 0.85
Duration
Never 110(85) 237(91) 1.00 256(85) 523(92) 1.00 1.00
< = Median 10(7.5) 13(5) 1.65 (0.67–4.06) 1.43(0.54–3.76) 26(9) 24(4) 2.44 (1.32–4.49) 1.69(0.87–3.26) 0.77
>Median 10(7.5) 10(4) 2.19 (0.85–5.65) 2.35(0.86–6.41) 18(6) 24(4) 1.69 (0.83–3.41) 1.33(0.62–2.81) 0.43.
Cumulative ***
Never 110(85) 237(91) 1.00 1.00 256(85) 523(92) 1.00 1.00
< = Median 9(7) 12(5) 1.61 (0.64–4.04) 1.42(0.50–3.95) 22(7) 25(4) 2.19 (1.08–3.73) 1.36(0.70–2.66) 0.95
>Median 11(8) 11(4) 2.20 (0.89–5.39) 2.25(0.86–5.85) 22(7) 23(4) 2.20 (1.15–4.21) 1.74(0.86–3.53) .68
Age Started
Never 110(85) 237(91) 1.00 1.00 256(85) 523(92) 1.00 1.00
>Median 12(9) 12(5) 1.56 (0.60–4.02) 1.65(0.59–4.55) 25(8) 27(5) 2.07 (1.06–4.04) 1.49(0.73–3.04) 0.88
< = Median 8(6) 11(4) 2.20 (0.93–5.18) 1.95(0.80–4.74) 19(6) 21(4) 2.11 (1.13–3.94) 1.56(0.79–3.06) 0.70
*

Adjusted for cigarette smoking, opium and hookah consumption, ethnicity, education and place of residence.

**

Median of control group in each set.

***

Cumulative = duration×amount.